Building business resilience: healthcare and pharma

Building business resilience: healthcare and pharma

Transitioning profitably towards the low-carbon economy is presenting healthcare and pharma companies with unprecedented market challenges. Companies face multiple threats to the bottom line, including tariffs, geopolitical risks, disruption to supply chains, and tightening emissions regulations.

The Risilience-powered platform, Riise, and team of specialists support global healthcare and pharma brands to quantify the financial impact of climate-and-nature-related risks and opportunities for growth and profitability. Riise enables businesses in this sector to:

• Leverage regulatory compliance for strategic advantage

• Embed sustainable supply chain management for business resilience

• Integrate climate and nature risk assessments into enterprise risk management programmes. Create repeatable mechanism to translate climate and nature risk into formal risk controls and investment decisions

• Identify and quantify physical and transition climate risks to sites and operations

• Surface trends and future issues using scenario analysis to inform capital planning

• Assess the financial value of decarbonising initiatives to optimise what, when and where provide best ROI

Climate change is disrupting business-as-usual and redefining the terms of success for many companies: transition planning that optimises timing and magnitude of decarbonising is key to achieving business success. Companies that address climate-related challenges early will thrive, while others will find their competitors have used the disruption to gain advantage.

How Risilience supports health and pharma

riise solution

Reporting and disclosure

Riise supports organisations to meet their global sustainability reporting obligations covering physical and transition risks across climate and nature with accuracy, consistency, traceability and credibility.

With a commercially focused approach, Riise enables the assessment of financial materiality across short-, medium- and long-term horizons under multiple emissions scenarios. Our outputs are aligned with global reporting frameworks including TCFD, CSRD, IFRS, ISSB, SB 261, TNFD, and EU Taxonomy, among others, ensuring regulatory readiness and strategic foresight.

Riise quantifies the financial impact of both transition and physical climate and nature risks, supporting commercially relevant insights for use across the business from executive leadership to individual business units, product categories, facilities, EHS, risk, finance, sustainability and procurement.

Riise delivers improved strategic planning, greater business resilience, aligned financial and sustainability outcomes, and informed, data-driven decision making.

*Share of population that are sustainable purchasers, 2040-2050*

riise solution

Strategic decision support

Risilience operationalises environmental intelligence across the business, driving future-focused decisions that strengthen long-term resilience to environmental risks.

Riise helps businesses prepare for and take advantage of the economic growth of the transition to the low-carbon economy. Sustainable businesses are more resilient to shocks from future carbon taxes, have better talent motivation and retention, and can avoid the downside shocks of technology change, stranded assets, liability and litigation penalties, and reputation damage.

riise solution

Transition planning and insights

Riise supports the creation of a credible and actionable transition plan, bringing together risk insights, financial quantification and fully costed initiatives into a single optimised view.

Forecast emissions change out to 2050 based on an organisation’s growth, wider economic decarbonisation trends and company-specific transition plans.

Riise enables businesses to stress test emission reduction forecasts considering different emission pathways and view the material impact of initiatives that drive net-zero goals.

Financially quantified information is captured to support the cost-benefit analysis of individual transition initiatives, employing Marginal Abatement Cost Curves to quantify reduction initiatives by maximum potential, technical feasibility and economic viability.

GHG emissions trajectories until 2050

*Future emission trajectories are subject to own initiatives in reducing emissions.*

Meet the Risilience team

	The place	The time
	GreenBiz 2026	17-19 February 2026, Phoenix, AZ.
	North American Sustainability & Responsibility Summit (NASRS 2026)	1-3 March 2026, Denver, CO
	Edie26	25-26 March 2026, London, UK